Literature DB >> 21121769

Allopurinol-thiopurine combination therapy in inflammatory bowel disease: are there genetic clues to this puzzle?

Rebecca L Roberts, Richard B Gearry, Murray L Barclay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21121769     DOI: 10.2217/pgs.10.143

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  3 in total

Review 1.  Use of thiopurines in inflammatory bowel disease: Safety issues.

Authors:  Anastasia Konidari; Wael El Matary
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

2.  Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction.

Authors:  Ana Luiza Vilar Guedes; Adriana Ribas Andrade; Vinicius Santos Nunes; Fabiana Roberto Lima; Evandro Sobroza de Mello; Suzane Kioko Ono; Débora Raquel Benedita Terrabuio; Eduardo Luiz Rachid Cançado
Journal:  Autops Case Rep       Date:  2017-06-30

Review 3.  Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.

Authors:  Kjeld Schmiegelow; Stine N Nielsen; Thomas L Frandsen; Jacob Nersting
Journal:  J Pediatr Hematol Oncol       Date:  2014-10       Impact factor: 1.289

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.